Article
Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway.
Pharmaceutical research - 1 Dec 2009
Rajamanickam Subapriya, Kaur Manjinder, Velmurugan Balaiya, Singh Rana P, Agarwal Rajesh
Abstract excerpt
PURPOSE: Here we assessed whether silibinin, a nontoxic chemopreventive agent, inhibits spontaneous intestinal tumorigenesis in APC ( min/+) mouse model, a genetically predisposed animal model of human familial adenomatous polyposis (FAP). MATERIALS AND METHODS: Six-week-old APC (min/+) mice were divided into four groups and orally gavaged with 0.2 ml vehicle, or 250, 500 and 750 mg silibinin/kg body weight in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
